- Home
- PCVX vs HAS Comparison
PCVX vs HAS Comparison
Compare PCVX & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | HAS |
|---|---|---|
| Founded | 2013 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 13.3B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PCVX | HAS |
|---|---|---|
| Price | $59.47 | $91.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $88.25 | ★ $109.73 |
| AVG Volume (30 Days) | 927.4K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.51 |
| Revenue | N/A | ★ $5,365,900,000.00 |
| Revenue This Year | N/A | $5.38 |
| Revenue Next Year | N/A | $6.48 |
| P/E Ratio | ★ N/A | $35.45 |
| Revenue Growth | N/A | ★ 13.06 |
| 52 Week Low | $30.81 | $69.50 |
| 52 Week High | $65.00 | $106.98 |
Technical Indicators
Market Signals| Indicator | PCVX | HAS |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 39.74 |
| Support Level | $58.51 | $88.03 |
| Resistance Level | $63.39 | $98.23 |
| Average True Range (ATR) | 2.10 | 1.97 |
| MACD | -0.39 | -0.92 |
| Stochastic Oscillator | 10.69 | 17.27 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to around 20 million digital tabletop players.